Guggenheim Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Guggenheim Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,902	Closed	-$638K	–	1743
2025 Q3	$638K	Sell	15,902 -2,002	-11%	-$75.3K	﹤0.01%	1087
2025 Q2	$595K	Sell	17,904 -851	-5%	-$25.8K	﹤0.01%	1092
2025 Q1	$550K	Buy	18,755 +5,052	+37%	+$168K	0.01%	1155
2024 Q4	$450K	Buy	+13,703	New	+$644K	﹤0.01%	1306
2020 Q4	–	Sell	-49,530	Closed	-$1.73M	–	2039
2020 Q3	$1.73M	Sell	49,530 -5,610	-10%	-$246K	0.01%	950
2020 Q2	$2.95M	Buy	55,140 +6,308	+13%	+$292K	0.02%	717
2020 Q1	$1.73M	Sell	48,832 -9,580	-16%	-$443K	0.02%	847
2019 Q4	$2.79M	Buy	58,412 +5,610	+11%	+$212K	0.02%	909
2019 Q3	$1.71M	Buy	52,802 +5,322	+11%	+$220K	0.01%	1081
2019 Q2	$2.37M	Sell	47,480 -250	-0.5%	-$13.4K	0.02%	981
2019 Q1	$3.22M	Sell	47,730 -968	-2%	-$56.4K	0.03%	854
2018 Q4	$2.25M	Sell	48,698 -2,881	-6%	-$178K	0.02%	984
2018 Q3	$3.98M	Buy	51,579 +5,470	+12%	+$440K	0.03%	852
2018 Q2	$3.88M	Sell	46,109 -2,915	-6%	-$254K	0.03%	870
2018 Q1	$4.01M	Sell	49,024 -2,040	-4%	-$158K	0.01%	1147
2017 Q4	$2.92M	Sell	51,064 -10,612	-17%	-$668K	0.01%	1382
2017 Q3	$4.12M	Sell	61,676 -786	-1%	-$47.2K	0.01%	1181
2017 Q2	$3.21M	Buy	62,462 +7,270	+13%	+$372K	0.01%	1279
2017 Q1	$3.22M	Buy	55,192 +4,920	+10%	+$236K	0.01%	1294
2016 Q4	$2.1M	Sell	50,272 -29,384	-37%	-$1.54M	0.01%	1645
2016 Q3	$4.21M	Buy	79,656 +14,617	+22%	+$637K	0.01%	1113
2016 Q2	$2.73M	Sell	65,039 -4,075	-6%	-$201K	0.01%	1359
2016 Q1	$2.81M	Sell	69,114 -22,186	-24%	-$949K	0.01%	1337
2015 Q4	$5.93M	Sell	91,300 -13,205	-13%	-$866K	0.02%	942
2015 Q3	$7.38M	Sell	104,505 -3,463	-3%	-$338K	0.02%	876
2015 Q2	$12M	Buy	107,968 +15,399	+17%	+$1.66M	0.03%	769
2015 Q1	$8.73M	Buy	92,569 +20,922	+29%	+$2.34M	0.02%	913
2014 Q4	$8.03M	Sell	71,647 -2,355	-3%	-$210K	0.02%	923
2014 Q3	$4.54M	Buy	74,002 +727	+1%	+$31.3K	0.01%	1247
2014 Q2	$3.36M	Buy	+73,275	New	+$2.99M	0.01%	1420